Maria De Fátima Silva De Lima
Biographic Data
| ID | 3669963 |
|---|---|
| NAME | Maria De Fátima Silva De Lima |
| GIVEN NAMES | Maria De Fátima Silva |
| FAMILY NAME | De Lima |
| SIGNATURE | DE LIMA M F S |
| AFFILIATIONS | Hospital das Clínicas de Pernambuco, Brasil |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 1 |
Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis
Hepatotoxicity due to antituberculosis drugs limits treatment in patients coinfected with HIV and tuberculosis. We conducted a case-control study to identify risk factors for hepatotoxicity among patients coinfected with tuberculosis and HIV in two hospitals in Recife, Pernambuco State, Brazil. The sample consisted of 57 patients (36.5% of the total) who developed hepatotoxicity and a control group of 99 patients (63.5% of the total), who did not…
Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis
Hepatotoxicity due to antituberculosis drugs limits treatment in patients coinfected with HIV and tuberculosis. We conducted a case-control study to identify risk factors for hepatotoxicity among patients coinfected with tuberculosis and HIV in two hospitals in Recife, Pernambuco State, Brazil. The sample consisted of 57 patients (36.5% of the total) who developed hepatotoxicity and a control group of 99 patients (63.5% of the total), who did not…
Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis
Hepatotoxicity due to antituberculosis drugs limits treatment in patients coinfected with HIV and tuberculosis. We conducted a case-control study to identify risk factors for hepatotoxicity among patients coinfected with tuberculosis and HIV in two hospitals in Recife, Pernambuco State, Brazil. The sample consisted of 57 patients (36.5% of the total) who developed hepatotoxicity and a control group of 99 patients (63.5% of the total), who did not…
Coinfection (1 works) · Drug-Induced Hepatotoxicity and Protection (1 works) · Gastroenterology (1 works) · Gastroenterology (1 works) · Hepatitis B (1 works) · Hepatitis C virus (1 works) · Human immunodeficiency virus (HIV) (1 works) · Immunology (1 works) · Immunology (1 works) · Internal Medicine (1 works)